These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 19777373)
1. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Verstappen SM; Watson K; Symmons DP; Qual Life Res; 2009 Nov; 18(9):1195-205. PubMed ID: 19777373 [TBL] [Abstract][Full Text] [Related]
2. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry. Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513 [TBL] [Abstract][Full Text] [Related]
3. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand. Dritsaki M; Petrou S; Williams M; Lamb SE Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833 [TBL] [Abstract][Full Text] [Related]
4. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B Ann Rheum Dis; 2012 Sep; 71(9):1478-83. PubMed ID: 22419775 [TBL] [Abstract][Full Text] [Related]
5. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061 [TBL] [Abstract][Full Text] [Related]
6. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400 [TBL] [Abstract][Full Text] [Related]
7. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse. Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D; Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259 [TBL] [Abstract][Full Text] [Related]
8. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412 [TBL] [Abstract][Full Text] [Related]
9. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253 [TBL] [Abstract][Full Text] [Related]
10. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis. Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316 [TBL] [Abstract][Full Text] [Related]
11. Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients. Zhang F; Yang Y; Huang T; Zhang Y; Zhao L; Li S Int J Rheum Dis; 2018 Jun; 21(6):1185-1192. PubMed ID: 27463704 [TBL] [Abstract][Full Text] [Related]
12. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility. Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977 [TBL] [Abstract][Full Text] [Related]
13. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure. Kontodimopoulos N; Argiriou M; Theakos N; Niakas D Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544 [TBL] [Abstract][Full Text] [Related]
14. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain. Ye Z; Sun L; Wang Q Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265 [TBL] [Abstract][Full Text] [Related]
15. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D. Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438 [TBL] [Abstract][Full Text] [Related]
16. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Obradovic M; Lal A; Liedgens H Health Qual Life Outcomes; 2013 Jul; 11():110. PubMed ID: 23815777 [TBL] [Abstract][Full Text] [Related]
17. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery. Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809 [TBL] [Abstract][Full Text] [Related]
18. Comparison of EQ-5D and SF-6D utilities in Pompe disease. Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117 [TBL] [Abstract][Full Text] [Related]
19. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study. Leung YY; Png ME; Wee HL; Thumboo J J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382 [TBL] [Abstract][Full Text] [Related]
20. A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population. Kangwanrattanakul K Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):765-774. PubMed ID: 32981380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]